Expressing support for the Texas Health and Human Services Commission's application to the Cell and Gene Therapy Access Model through the Centers for Medicare and Medicaid Services and its Center for Medicare and Medicaid Innovation.

HCR 103 is a symbolic concurrent resolution expressing Texas' support for the Texas Health and Human Services Commission's application to the federal Cell and Gene Therapy Access Model (CGT Access Model). The resolution supports Texas' effort to join this CMS program, which aims to create outcomes-based payment agreements between states, manufacturers, and CMS to improve access to high-cost cell and gene therapies for Medicaid patients with rare diseases. It does not change any laws or create new programs - it merely states legislative backing for Texas' application to test this model. The resolution directly affects Texas Medicaid beneficiaries by potentially expanding access to transformative therapies while seeking to lower long-term state healthcare costs.